Results 151 to 160 of about 207,835 (296)

A single gene mutation predicts response to immune checkpoint blockade in ovarian clear cell carcinoma

Molecular Oncology, EarlyView.
Loss‐of‐function mutations in the scaffold subunit of protein phosphatase 2A (PP2A), PPP2R1A, sensitize ovarian clear cell carcinoma to immune checkpoint blockade (ICB) by enhancing the interferon gamma response and promoting antitumor immune cell infiltration.
Matheus Henrique Dias, René Bernards
wiley   +1 more source

Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections. [PDF]

Mol Biotechnol, 2023
Khairkhah N, Namvar A, Bolhassani A.
europepmc   +1 more source

New magnetic drug carrier

Journal of Pharmacy and Pharmacology, 1983
Patrick Couvreur, Peter Speiser, Marie Roland, A. Ibrahim   +3 more
openaire   +3 more sources

Long non‐coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application

FEBS Open Bio, EarlyView.
Long non‐coding RNAs (lncRNAs) occupy an abundant fraction of the eukaryotic transcriptome and an emerging area in cancer research. Regulation by lncRNAs is based on their subcellular localization in HNSCC. This cartoon shows the various functions of lncRNAs in HNSCC discussed in this review.
Ellen T. Tran, Ruchi A. Patel, Amogh Chariyamane, Ratna B. Ray   +3 more
wiley   +1 more source

Correction: Modified diatom-based ocular suspension for sustained diclofenac sodium delivery: a novel drug carrier approach. [PDF]

BMC Pharmacol Toxicol
Ghasemishayan R, Jalaei D, Dobakhti F.
europepmc   +1 more source

Erratum: Development of a quaternary ammonium poly (amidoamine) dendrimer-based drug carrier for the solubility enhancement and sustained release of furosemide. [PDF]

Front Chem, 2023
Frontiers Production Office.
europepmc   +1 more source

Drug-Squeezing Effect in Tablets with .KAPPA.-Carrageenan and Methyl Glycol Chitosan as Drug Carriers.

, 2001
Shintarou KANBAYASHI
openalex   +2 more sources

Gut alterations in a chronic kidney disease rat model with diet‐induced vascular calcification

FEBS Open Bio, EarlyView.
Chronic kidney disease (CKD) patients often suffer from intestinal and/or mineral and bone disorders. Using a rat model, we showed that uremic vascular calcification is associated with gut barrier alterations (decreased gut mucus production and Nlrp6 gene expression, increased gut inflammation), and plasma retention of gut‐origin uremic toxins (indoxyl
Piotr Bartochowski, Irene Cortijo, Shruti Bhargava, Bernard Jover, Fabrice Raynaud, Juliana H Boukhaled, Anne‐Dominique Lajoix, Vera Jankowski, Joachim Jankowski, Magali Cordaillat‐Simmons, Àngel Argilés, Nathalie Gayrard, Flore Duranton, Jonas Laget   +13 more
wiley   +1 more source

Sevelamer arsenite nanoparticle as a Pi-responsive drug carrier and embolic agent for chemoembolization. [PDF]

Drug Deliv, 2022
Bi QC, Tang JJ, Zhao J, Lv YF, Deng ZQ, Chen H, Xu YH, Xie CS, Liang QR, Luo RG, Tang Q.   +10 more
europepmc   +1 more source

Development of particulate drug carriers based on the analysis of important determinants in their disposition.

, 2001
Ken‐ichi Ogawara, Kazutaka Higaki, Toshikiro Kimura   +2 more
openalex   +2 more sources